Myriad Genetics to Participate in Important Investor Healthcare Conferences
Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent player in genetic testing and precision medicine, has announced that its management team will take part in two significant upcoming investor healthcare conferences.
Details of the Upcoming Conferences
At the Wells Fargo Healthcare Conference, Scott Leffler, the Chief Financial Officer, will engage in a fireside chat on a specified date at 1:30 PM ET.
Meanwhile, the Morgan Stanley Healthcare Conference will feature Paul J. Diaz, the President and CEO, who will also participate in a fireside chat on a specified date at 7:00 AM ET.
About Myriad Genetics
Myriad Genetics is a leading company in genetic testing and precision medicine, committed to enhancing health and well-being for everyone. The company develops and provides genetic tests that evaluate the risk of disease development or progression, guiding treatment decisions across various medical fields where genetic insights can greatly enhance patient care and reduce healthcare costs. To learn more, visit www.myriad.com.
Investor Contact Information
Matt Scalo
(801) 584-3532
IR@myriad.com
Media Contact Information
Glenn Farrell
(385) 318-3718
PR@myriad.com
Frequently Asked Questions
What is Myriad Genetics known for?
Myriad Genetics is recognized for its innovations in genetic testing and precision medicine.
Who will be speaking at the upcoming conferences?
Scott Leffler and Paul J. Diaz are the speakers for their respective conferences.
When are the upcoming healthcare conferences?
The specific dates for these conferences are included in the announcement.
How can I find out more about Myriad Genetics?
For additional information, you can visit their official website at www.myriad.com.
What are the contact details for Myriad's investor relations?
The investor relations contact is Matt Scalo, reachable at (801) 584-3532 or via email at IR@myriad.com.